Recombinant Zoster Vaccine (Shingrix): a nex gun for Rheumatologist
Herpes Zoster, or as commonly known shingles, is a debilitating painful rash occurring at any age in anyone caused by reactivation of the varicella zoster virus (VZV). The lifetime risk of HZ in the general population is around 30% HZ incidence increases with age and is estimated that 90% of adults...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Verduci Editore,
2022-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Herpes Zoster, or as commonly known shingles, is a debilitating painful rash occurring at any age in anyone caused by reactivation of the varicella zoster virus (VZV). The lifetime risk of HZ in the general population is around 30% HZ incidence increases with age and is estimated that 90% of adults have contracted VZV and are therefore at risk of developing HZ and that at least 1 in 3 individuals will develop the disease in their lifetime. Increased HZ incidence, attributed to a decline in immunity, is observed in elderly people and in patients using immunosuppressive medications. In light of the significant burden caused by HZ and its complications in frail patients, adopting a preventive strategy seems promising, particularly using vaccination in appropriate age and risk groups. |
|---|---|
| Item Description: | 2612-5110 10.53238/br_20223_375 |